Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

121. Screening for breast cancer: an update for the U.S. preventive services task force

Screening for breast cancer: an update for the U.S. preventive services task force Screening for breast cancer: an update for the U.S. preventive services task force Screening for breast cancer: an update for the U.S. preventive services task force Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L CRD summary This review focused on the effectiveness of mammography and clinical breast examination in decreasing breast cancer mortality. The authors concluded that mammography can reduce (...) of Related Interest) was updated with reference to MEDLINE (January 2001 to December 2008) and The Cochrane Library (fourth quarter of 2008). Search terms were reported. Reference lists were reviewed and citation searching was carried out through Web of Science. Data were obtained from the Breast Cancer Surveillance Consortium (BCSC). Study selection Randomised controlled trials (RCTs) and updates to previously published trials of mammography screening (film and digital) and clinical breast examination

DARE.2009

122. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Noble M, Bruening W, Uhl S, Schoelles K CRD summary This review assessed the diagnostic performance of computer-aided detection mammography for breast cancer screening. No conclusions were (...) drawn for diagnostic performance. The authors' statement that the benefits and risks of computer-aided detection should be considered carefully as data were not available to determine whether the incremental cancer detection rate was associated with changes in patient outcomes was a reasonable interpretation. Authors' objectives To assess the diagnostic performance of computer-aided detection mammography in screening for breast cancer. Searching Seventeen bibliographic databases, including MEDLINE

DARE.2009

123. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

Health Technology Assessment (HTA) Database.2009

124. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society (...) cancer, cancer, or all cause mortality but increased breast surgeries Article Text Treatment Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s

Evidence-Based Nursing (Requires free registration)2008

125. Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women

Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women Article Text Therapeutics Annual mammographic screening beginning at 40 years of age did

Evidence-Based Medicine (Requires free registration)2008

126. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:006083 This guideline summary

American Cancer Society2008

127. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost (...) of economic evaluation Cost-effectiveness analysis Study objective The objective was to evaluate the clinical and economic impact of breast screening with ultrasound (US) in self-referring women with dense breasts and a negative report on mammography, in comparison with mammography alone. Interventions The study examined the use of bilateral US in women with negative Breast Imaging Reporting and Data System (BI-RADS) D3 and D4 mammography. US findings classified as indeterminate, suspicious or malignant

NHS Economic Evaluation Database.2008

128. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia

Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia Rojnik K, Naversnik K, Mateovic-Rojnik T, PrimicZakelj M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the cost-effectiveness of alternative strategies of population-level screening against breast cancer in Slovenia. The screening modalities varied depending on screening interval and age eligibility criteria. The authors demonstrated that the most cost-effective strategy was screening women aged 40 to 80 years

NHS Economic Evaluation Database.2008

129. Cost-effectiveness of digital mammography breast cancer screening

Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Tosteson A N, Stout N K, Fryback D G, Acharyya S, Herman B A, Hannah L G, Pisano E D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study aimed to determine the cost-effectiveness of digital mammography screening, compared with film mammography screening, for the detection of breast cancer (BC) in women aged 40 years or more than 65 years. The study showed that screening for BC using all-digital mammography is not cost-effective, while age-targeted screening with digital mammography has the potential to be cost-effective

NHS Economic Evaluation Database.2008

130. Breast Tomosynthesis: a breast cancer screening tool

Breast Tomosynthesis: a breast cancer screening tool Breast Tomosynthesis: a breast cancer screening tool Breast Tomosynthesis: a breast cancer screening tool Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mundy L, Hiller JE. Breast Tomosynthesis: a breast cancer screening tool. Adelaide: Adelaide Health Technology (...) Assessment (AHTA). Prioritising Summary. Volume 21. 2008 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Imaging, Three-Dimensional; Mammography Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence Adelaide Health Technology Assessment, University of Adelaide, Discipline of Public Health, School of Population Health and Clinical Practice, Mail Drop DX650545, SA 5005

Health Technology Assessment (HTA) Database.2008

131. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D CRD summary This review evaluated the diagnostic accuracy of adding magnetic resonance imaging (MRI) to annual mammographic screening (...) of women at high genetic risk of breast cancer. The authors concluded that MRI plus mammography may be better than mammography alone for ruling out breast cancer. The review had some limitations, but the authors' cautious conclusions reflected the evidence presented and appeared appropriate. Authors' objectives To determine the diagnostic accuracy of adding magnetic resonance imaging (MRI) to annual mammographic screening of women at very high risk of breast cancer. Searching EMBASE, MEDLINE

DARE.2008

132. Quality assurance guidelines for clinical nurse specialists in breast cancer screening

Quality assurance guidelines for clinical nurse specialists in breast cancer screening QUALITY ASSURANCE GUIDELINES FOR CLINICAL NURSE SPECIALISTS IN BREAST CANCER SCREENING NHSBSP Publication No 29 Fourth edition January 2008 Published by: NHS Cancer Screening Programmes Fulwood House Old Fulwood Road Sheffield S10 3TH Tel: 0114 271 1060 Fax: 0114 271 1089 Email: info@cancerscreening.nhs.uk Web site: www.cancerscreening.nhs.uk © NHS Cancer Screening Programmes 2008 The contents (...) 2008 iii Quality Assurance Guidelines for Clinical Nurse Specialists in Breast Cancer Screening CONTENTS Page No PREFACE iv 1. INTRODUCTION 1 1.1 Background 1 1.2 Aim of this publication 1 2. STANDARDS FOR BREAST CARE NURSING (SCREENING) 2 2.1 Philosophy 2 2.2 Working arrangements 2 2.3 Standard 1: preparation to practise as a CNS in breast care (screening) 5 2.4 Standard 2: standards of practice for a CNS in breast care (screening) 6 3. QUALITY ASSURANCE FRAMEWORK 8 3.1 Responsibilities

Publication 10832008

133. Cost-effectiveness of digital mammography breast cancer screening.

Cost-effectiveness of digital mammography breast cancer screening. BACKGROUND: The DMIST (Digital Mammography Imaging Screening Trial) reported improved breast cancer detection with digital mammography compared with film mammography in selected population subgroups, but it did not assess the economic value of digital relative to film mammography screening. OBJECTIVE: To evaluate the cost-effectiveness of digital mammography screening for breast cancer. DESIGN: Validated, discrete-event (...) with dense breasts). OUTCOME MEASURES: Cost per quality-adjusted life-year (QALY) gained. RESULTS OF BASE-CASE ANALYSIS: All-digital mammography screening cost $331,000 (95% CI, $268,000 to $403,000) per QALY gained relative to all-film mammography screening but was more costly and less effective than targeted digital mammography screening. Targeted digital mammography screening resulted in more screen-detected cases of cancer and fewer deaths from cancer than either all-film or all-digital mammography

Annals of Internal Medicine2008 Full Text: Link to full Text with Trip Pro

134. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. 18477782 2008 05 14 2008 05 20 2016 12 15 1538-3598 299 18 2008 May 14 JAMA JAMA Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. 2151-63 10.1001/jama.299.18.2151 Screening ultrasound may depict small, node-negative breast cancers not seen on mammography. To compare the diagnostic yield, defined as the proportion (...) of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer. From April 2004 to February 2006, 2809 women, with at least heterogeneously dense breast tissue in at least 1 quadrant, were recruited from 21 sites to undergo mammographic and physician-performed ultrasonographic examinations in randomized order by a radiologist masked to the other examination results

JAMA2008 Full Text: Link to full Text with Trip Pro

135. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young (...) women at high risk of breast cancer Lord S J, Lei W, Craft P, Cawson J N, Morris I, Walleser S, Griffiths A, Parker S, Houssami N CRD summary This review found that adding breast magnetic resonance imaging (MRI) to conventional screening results in a very sensitive strategy for the early detection of breast cancer in young high- risk women. It is unclear to what extent high-risk young women receive the same benefits from early detection and treatment of MRI-detected cancers. These finding are likely

DARE.2007

136. Magnetic Resonance Imaging Screening of Women at High Risk for Breast Cancer

Magnetic Resonance Imaging Screening of Women at High Risk for Breast Cancer The Cancer Care Ontario website has moved - CCO Search CCO The Cancer Care Ontario website has moved To find what you’re looking for, go to and search by keywords. Last modified: Tue, Nov 07, 2017 cancer care ontario | action cancer ontario 620 University Avenue Toronto Ontario, Canada M5G 2L7 Phone: 416.971.9800 Fax: 416.971.6888

Cancer Care Ontario2007

137. [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening]

[Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening] Informacion a usuarias sobre el cribado de cancer en la mujer: Evaluacion de la situacion actual y establecimiento de estandares de informacion basada en la evidencia: 1. Informacion a usuarias sobre el cribado de cancer de mama [Information to users on cancer screening in women: assessment of current (...) situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening] Informacion a usuarias sobre el cribado de cancer en la mujer: Evaluacion de la situacion actual y establecimiento de estandares de informacion basada en la evidencia: 1. Informacion a usuarias sobre el cribado de cancer de mama [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information

Health Technology Assessment (HTA) Database.2007

138. Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer

Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer Dunfield L, Severn M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Dunfield L, Severn M. Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Technology Report No 93. 2007 Authors' objectives "Research Questions; 1. What is the clinical effectiveness of MRI screening compared to film mammography in women with a high risk of breast cancer? 2. What is the cost-effectiveness of MRI screening compared to film mammography

Health Technology Assessment (HTA) Database.2007

139. Magnetic resonance imaging for breast cancer screening in women at high risk

Magnetic resonance imaging for breast cancer screening in women at high risk Magnetic resonance imaging for breast cancer screening in women at high risk Magnetic resonance imaging for breast cancer screening in women at high risk Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Magnetic resonance imaging for breast cancer screening in women at high risk (...) . Lansdale: HAYES, Inc.. Directory Publication. 2007 Authors' objectives The objectives of using magnetic resonance imaging (MRI) to screen women at high risk for breast cancer are to improve the sensitivity of screening in this group of women, with the goal of providing early diagnosis and reducing the mortality rate associated with breast cancer. Project page URL Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms /prevention

Health Technology Assessment (HTA) Database.2007

140. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Medical Advisory Secretariat Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Medical Advisory Secretariat. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Toronto: Medical Advisory Secretariat (MAS). Volume 7(1). 2007 Authors' objectives The aim of this review was to determine the effectiveness of screening mammography in women aged 40 to 49 years at average risk for breast cancer. The following questions were asked: Does screening

Health Technology Assessment (HTA) Database.2007